Sensex slides 111 points, Nifty tad below 10100

The broader NSE Nifty, which hit a record high earlier in the session, closed down 0.05 percent at 10,147.55.

US Federal Reserave meet on Wednesday were on expected lines - interest rates were kept unchanged but possibility of one rate hike by December end remains. "Ashok Leyland, Asian Granito, Bombay Dyeing, Centrum Capital, Hexaware Tech, IGL, Meghmani Organics, Punj Lloyd, Trident and Yes Bank, among others, were among those stocks", Desai told IANS.

The markets however may see a shift in mood depending upon the fallout of Federal Reserve meeting in the US.

On Wednesday, the rupee had logged its first gain in three sessions by rising 6 paise. Almost two shares declined for every share rising on the BSE.

The 30-scrip Sensitive Index (Sensex) of the BSE, which opened at 32,522.44 points, closed at 32,402.37 points - down 21.39 points, or 0.07 per cent, from its previous close at 32,423.76 points.

Pharma stocks were star performers of the day as the Nifty Pharma index ended with 3.3 percent gains following positive regulatory developments.

But Dr Reddy's Laboratories surged over 7.7 percent after the drugmaker said it got establishment inspection report from USA drug regulator for its Srikakulam plant.

The company also received an establishment inspection report from the U.S. Food and Drug Administration for an audit of its plant in Andhra Pradesh, it said in an exchange filing. Cadila Healthcare was up 3.5 percent as Zydus received approval from the United States health regulator for Itraconazole 100 mg capsules.

Major Sensex losers were: Tata Motors (DVR), down 2.14 per cent at Rs 233.25; ICICI Bank, down 1.99 per cent at Rs 285; Axis Bank, down 1.37 per cent at Rs 512.25; Coal India, down 1.09 per cent at Rs 253.60; and ONGC, down 0.93 per cent at Rs 166. While, domestic institutional investors (DIIs) bought shares worth a net Rs 946.23 crore.

Vivimed Labs rose 3 percent as its Hyderabad FDF manufacturing unit was approved & accredited with Good Manufacturing Practice Certificate from Ukraine ministry of Health. "Also, the concern on valuation and lack of supportive cues to outpace the resistance influenced investors to book some profit", said Vinod Nair, Head of Research, Geojit Financial Services Ltd.

  • Delores Daniels